NCT06682039Completed
Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors
Anxiety and Negative Attentional Bias in Adolescent and Young Adult Cancer Survivors
Source: ClinicalTrials.gov · Last updated 30 Jan 2026
Brief summary (registry, in English)
This clinical trial studies how well attention bias modification (ABM) improves anxiety in adolescent and young adult (AYA) cancer survivors. Cancer-related anxiety is the most prevalent mental health problem affecting AYA cancer survivors. Cancer-related anxiety is associated with long-term negative outcomes such as poor quality of life, depression, distress, substance use, sleep problems, fatigue, and pain. ABM uses techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. ABM uses brief self-guided smartphone applications. Patients complete repetitive association reaction-time tasks targeting automatic and unconscious negative attention biases to retrain attention away from perceived threat and towards a neutral or positive stimuli. Gratitude-finding and savoring activities are also provided to maintain and increase positive emotions. Using ABM plus gratitude-finding and savoring activities may improve anxiety in AYA cancer survivors.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 7 Nov 2024
- Start date
- 8 Nov 2024
- Primary completion date
- 12 Jan 2026
- Lead sponsor
- Fred Hutchinson Cancer Center
- Diseases
- Childhood cancers
- NCT number
- NCT06682039
What you commit to
- Study type: Interventional
- Participants enrolled: 70
- From 8 Nov 2024 to the primary completion date, 12 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients on active/curative cancer treatment
Other
- Cognitively or physically unable to participate in ABM intervention and surveys
- Patients who cannot understand/read/write English will be excluded from the research because the ABM intervention is currently only available in English
- Furthermore, patients who do not have access to technology (smartphone/computer) will be excluded from the study as this technology is absolutely required to engage in the study intervention
Who the study is looking for
- Age 15-29 years
- Diagnosis of cancer malignancy
- Received active/curative cancer treatment OR received/actively receiving cancer survivorship care at Seattle Children's Hospital (SCH) or other study referring site (e.g. St. Jude)
- Currently off active/curative cancer treatment
- Patient able to understand/read/write English language
- Cognitively able to participate in ABM intervention and complete surveys
- Patient has access to smartphone able to send and receive text messages
- Patient has access to computer or smartphone for Inquisit program
Age in the registry: 15 years to 29 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fred Hutch/University of Washington/Seattle Children's Cancer Consortium Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.